Sguassero Yanina, de Onis Mercedes, Bonotti Ana María, Carroli Guillermo
Centro Rosarino de Estudios Perinatales, Rosario, Argentina..
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD005039. doi: 10.1002/14651858.CD005039.pub3.
Supplementary feeding is defined as the provision of extra food to children or families beyond the normal ration of their home diets. The impact of food supplementation on child growth merits careful evaluation in view of the reliance of many states and non-governmental organisations on this intervention to improve child health in low and middle income countries (LMIC). This is an update of a Cochrane review first published in 2005.
To evaluate the effectiveness of community-based supplementary feeding for promoting the physical growth of children under five years of age in LMIC.
For this updated review we searched the following databases on 31 January 2011: CENTRAL (The Cochrane Library), MEDLINE (1948 to January week 3, 2011), EMBASE (1980 to week 3, 2011), CINAHL (1937 to 27 January 2011), LILACS (all years), WorldCat for dissertations and theses (all years) and ClinicalTrials.gov (all years).
Randomised controlled trials (RCTs) evaluating supplementary feeding in comparison to a control group (no intervention or a placebo such as food with a very low number of nutrients and calories) in children from birth to five years of age in LMIC.
Two review authors independently extracted and analysed the data.
We included eight RCTs (n = 1243 children) that were at relatively high risk of bias. We found high levels of clinical heterogeneity in the participants, interventions and outcome measures across studies. Nevertheless, in order to quantify pooled effects of supplementary feeding, we decided to combine studies according to prespecified characteristics. These were the children's age (younger or older than 24 months), their nutritional status at baseline (stunted or wasted, or not stunted or wasted) and the duration of the intervention (less or more than 12 months). A statistically significant difference of effect was only found for length during the intervention in children aged less than 12 months (two studies; 795 children; mean difference 0.19 cm; 95% confidence interval (CI) 0.07 to 0.31). Based on the summary statistic calculated for each study, the mean difference (MD) between intervention and control groups ranged from 0.48 cm (95% CI 0.07 to 0.89) to 1.3 cm (95% CI 0.03 to 2.57) after 3 and 12 months of intervention, respectively. Data on potential adverse effects were lacking.
AUTHORS' CONCLUSIONS: The scarcity of available studies and their heterogeneity makes it difficult to reach any firm conclusions. The review findings suggest supplementary feeding has a negligible impact on child growth; however, the pooled results should be interpreted with great caution because the studies included in the review are clinically diverse. Future studies should address issues of research design, including sample size calculation, to detect meaningful clinical effects and adequate intervention allocation concealment. In the meantime, families and children in need should be provided appropriate feeding, health care and sanitation without waiting for new RCTs to establish a research basis for feeding children.
辅食喂养是指在家庭日常饮食正常定量之外,为儿童或家庭提供额外食物。鉴于许多国家和非政府组织依赖这种干预措施来改善低收入和中等收入国家(LMIC)儿童的健康状况,因此有必要仔细评估食物补充对儿童生长发育的影响。这是对2005年首次发表的Cochrane综述的更新。
评估在LMIC中,基于社区的辅食喂养对促进五岁以下儿童身体生长的有效性。
在2011年1月31日,我们检索了以下数据库:Cochrane系统评价数据库(CENTRAL)、医学索引数据库(MEDLINE,1948年至2011年第3周)、荷兰医学文摘数据库(EMBASE,1980年至2011年第3周)、护理学与健康照护数据库(CINAHL,1937年至2011年1月27日)、拉丁美洲及加勒比地区健康科学数据库(LILACS,所有年份)、世界图书馆学位论文数据库(WorldCat,所有年份)以及临床试验注册库(ClinicalTrials.gov,所有年份)。
随机对照试验(RCT),评估在LMIC中,从出生到五岁的儿童,与对照组(无干预或安慰剂,如营养成分和热量极低的食物)相比,辅食喂养的效果。
两位综述作者独立提取并分析数据。
我们纳入了八项RCT(共1243名儿童),这些研究存在较高的偏倚风险。我们发现,各项研究在参与者、干预措施和结局指标方面存在高度的临床异质性。尽管如此,为了量化辅食喂养的综合效果,我们决定根据预先设定的特征对研究进行合并。这些特征包括儿童的年龄(24个月以下或以上)、基线时的营养状况(发育迟缓或消瘦,或未发育迟缓或消瘦)以及干预持续时间(少于或多于12个月)。仅在干预期间发现,12个月以下儿童的身长有统计学显著差异(两项研究;795名儿童;平均差值0.19厘米;95%置信区间(CI)0.07至0.31)。根据每项研究计算的汇总统计量,干预组与对照组之间的平均差值(MD)在干预3个月和12个月后分别为0.48厘米(95%CI 0.07至0.89)和1.3厘米(95%CI 0.03至2.57)。缺乏关于潜在不良反应的数据。
现有研究数量稀少且存在异质性,难以得出任何确凿结论。综述结果表明,辅食喂养对儿童生长的影响微乎其微;然而,由于纳入综述的研究在临床上存在差异,对汇总结果的解释应极为谨慎。未来的研究应解决研究设计问题,包括样本量计算,以检测有意义的临床效果,并进行充分的干预分配隐藏。与此同时,应向有需要的家庭和儿童提供适当的喂养、医疗保健和卫生条件,而无需等待新的RCT来为儿童喂养建立研究基础。